Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Harvard Business School
Covington
Colorcon
Baxter
Julphar
Boehringer Ingelheim
Fuji

Generated: April 24, 2018

DrugPatentWatch Database Preview

ORLAAM Drug Profile

« Back to Dashboard

Which patents cover Orlaam, and when can generic versions of Orlaam launch?

Orlaam is a drug marketed by Roxane and is included in one NDA.

The generic ingredient in ORLAAM is levomethadyl acetate hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levomethadyl acetate hydrochloride profile page.
Drug patent expirations by year for ORLAAM
Synonyms for ORLAAM
(-)-(3S,6S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester), hydrochloride
(-)-|A-Acetylmethadol
(-)-|A-Acetylmethadol Hydrochloride
(-)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol Acetate (Ester) Hydrochloride
(-)-alpha-Acetylmethadol Hydrochloride
(|AS)-|A-[(2S)-2-(Dimethylamino)propyl]-|A-ethyl-|A-phenyl-benzeneethanol acetate (ester) hydrochloride hydrochloride
(|AS)-|A-[(2S)-2-(Dimethylamino)propyl]-|A-ethyl-|A-phenylbenzeneethanol Acetate (Ester) Hydrochloride
(1S,4S)-4-(dimethylamino)-1-ethyl-2,2-diphenylpentyl acetate hydrochloride
(1S)-2-[(2S)-2-(dimethylamino)propyl]-1-ethyl-2,2-diphenylethyl acetate hydrochloride
(3S,6S)-(-)- 6-(Dimethylamino)-4,4-diphenyl-3-heptanol Acetate (Ester) Hydrochloride
(alphaS)-beta-[(2S)-2-(Dimethylamino)propyl]-alpha-ethyl-beta-phenyl-benzeneethanol acetate (ester) hydrochloride hydrochloride
[(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate hydrochloride
3-Heptanol, 6-(dimethylamino)-4,4-diphenyl-, acetate (ester), hydrochloride, (3S,6S)-(-)-
4-(dimethylamino)-1-ethyl-2,2-diphenylpentyl acetate hydrochloride
43033-72-3
5989-56-0
6-Dimethylamino-4,4-diphenyl-3-heptanolacetate.HCl
AC1L21LS
alpha-1-Acetylmethadol hydrochloride
alpha-l-Acetylmethadol hydrochloride
B54CW5KG52
Benzeneethanol, beta-(2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester), hydrochloride, (S-(R*,R*))-
C23H31NO2.HCl
CCRIS 3321
CHEBI:6442
CHEMBL1200817
D00840
DTXSID7020500
FT-0663074
Hydrochloride LAAM
l-|A-Acetylmethadol Hydrochloride
l-Acetylmethadol hydrochloride
l-alpha-Acetylmethadol hydrochloride
LAAM hydrochloride
LAAM hydrochloride, >=98% (HPLC), solid
Levacetyl methadol hydrochloride
Levacetylmethadol Hydrochloride
Levo-|A-acetylmethadol Hydrochloride
Levomethadyl acetate HCl
Levomethadyl acetate hydrochloride
Levomethadyl acetate hydrochloride (USAN)
Levomethadyl acetate hydrochloride [USAN]
Levomethadyl Hydrochloride
LS-7348
MFCD01723736
MK 790
MK-790
MK-790 hydrochloride
MLS002320666
Orlaam (TN)
ORLAAM hydrochloride
SCHEMBL79093
SMR001338812
UNII-3ZD9WAO92T component UXBPQRGCVJOTNT-COBSGTNCSA-N
UNII-B54CW5KG52

US Patents and Regulatory Information for ORLAAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane ORLAAM levomethadyl acetate hydrochloride CONCENTRATE;ORAL 020315-001 Jul 9, 1993 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Dow
Moodys
McKinsey
Johnson and Johnson
Baxter
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.